Sign in to view content

An Analysis of Particle Contamination and Protein Aggregation From Syringes Used for Intravitreal Injection

Jason Noble, MD, FRCSC

Video
Published 2021

Related

The Conundrum of Intravitreal Injections and Use of -25 Modifier for Same-Day Office Visits
John T. Thompson, MD
Annual Meeting Talks
2021
Particulate Matter From Syringes Used for Intravitreal Injections
Roger A. Goldberg, MD, MBA
Annual Meeting Talks
2020
Safety Results of ONS-5010, an Ophthalmic Bevacizumab, in Treated Eyes of Patients With Wet AMD, DME, and BRVO
Suber S. Huang, MD, MBA, FASRS
Annual Meeting Talks
2021

Category: Instrumentation and Devices

See more